Kahlmeyer, A.; Stöhr, C.G.; Hartmann, A.; Goebell, P.J.; Wullich, B.; Wach, S.; Taubert, H.; Erlmeier, F.
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. J. Clin. Med. 2019, 8, 743.
https://doi.org/10.3390/jcm8050743
AMA Style
Kahlmeyer A, Stöhr CG, Hartmann A, Goebell PJ, Wullich B, Wach S, Taubert H, Erlmeier F.
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. Journal of Clinical Medicine. 2019; 8(5):743.
https://doi.org/10.3390/jcm8050743
Chicago/Turabian Style
Kahlmeyer, Andreas, Christine G. Stöhr, Arndt Hartmann, Peter J. Goebell, Bernd Wullich, Sven Wach, Helge Taubert, and Franziska Erlmeier.
2019. "Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma" Journal of Clinical Medicine 8, no. 5: 743.
https://doi.org/10.3390/jcm8050743
APA Style
Kahlmeyer, A., Stöhr, C. G., Hartmann, A., Goebell, P. J., Wullich, B., Wach, S., Taubert, H., & Erlmeier, F.
(2019). Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. Journal of Clinical Medicine, 8(5), 743.
https://doi.org/10.3390/jcm8050743